COPEGUS Side Effects

6296383-0 | Staphylococcal Sepsis
on Jul 21, 2009 Female patient from JAPAN , weighting 152.1 lb, was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: staphylococcal sepsis. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), URSO 250 (Dosage Form Reported As: Oral Formulation (not Otherwise Specified)) (View Urso 250 Review and Urso 250 Label ), ALESION (View Alesion Review and Alesion Label ), PROMAC (View Promac Review and Promac Label ), TAKEPRON (View Takepron Review and Takepron Label ), DEPAS (View Depas Review and Depas Label ), AMOBAN (View Amoban Review and Amoban Label ).

6261697-7 | Erythema Multiforme, Platelet Count Decreased, Pyrexia, Renal Failure Acute
Patient was taking Copegus (View Usage). Patient had the following side effects: erythema multiforme, platelet count decreased, pyrexia, renal failure acute on Jun 26, 2009 from JAPAN Additional patient health information: Female patient , weighting 152.1 lb, . Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), URSO 250 (Dosage Form Reported As: Oral Formulation (not Otherwise Specified)) (View Urso 250 Review and Urso 250 Label ), ALESION (View Alesion Review and Alesion Label ), PROMAC (View Promac Review and Promac Label ), TAKEPRON (View Takepron Review and Takepron Label ), DEPAS (View Depas Review and Depas Label ), AMOBAN (View Amoban Review and Amoban Label ). Patient was hospitalized.

6255863-4 | Congenital Torticollis, Polyhydramnios, Premature Labour, Umbilical Cord Vascular Disorder
Adverse event was reported on Jun 19, 2009 by a Female patient taking Copegus (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, pregnancy (What is pregnancy?) and. Location: UNITED STATES , weighting 4.19 lb, After Copegus was administered, patient had the following side effects: congenital torticollis, polyhydramnios, premature labour, umbilical cord vascular disorder. During the same period patient was treated with PEG INTERFERON ALFA NOS (View Peg-interferon Alfa Nos Review and Peg-interferon Alfa Nos Label ), HUMALOG (1 Dose In The Morning, 1 Dose In The Evening.) (View Humalog Review and Humalog Label ), HUMULIN R (Reported As Humilin.) (View Humulin R Review and Humulin R Label ), INSULIN (View Insulin Review and Insulin Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ).

6253998-3 | Skull Malformation
on Jun 19, 2009 Male patient from UNITED STATES , weighting 5.73 lb, was diagnosed with epilepsy (What is epilepsy?), hepatitis c (What is hepatitis c?), hypothyroidism and was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: skull malformation. Copegus dosage: Gestation Week: 17. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), VIRAFERONPEG (Form Injectable Solution) (View Viraferonpeg Review and Viraferonpeg Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), DEROXAT (View Deroxat Review and Deroxat Label ), PEG INTERFERON ALFA NOS (View Peg-interferon Alfa Nos Review and Peg-interferon Alfa Nos Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), CYSTINE B6 (View Cystine-b6 Review and Cystine-b6 Label ).


6234430-2 | Venous Occlusion
on Jun 08, 2009 Female patient from JAPAN , 69 years of age, was diagnosed with hepatitis (What is hepatitis?) and was treated with Copegus (View Usage). Patient had the following side effects: venous occlusion. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6186780-6 | Menorrhagia
Patient was taking Copegus (View Usage). After Copegus was administered, patient had the following side effects: menorrhagia on Apr 27, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 44 years of age, weighting 119.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6176047-4 | Pulmonary Haemorrhage
Adverse event was reported on Apr 22, 2009 by a Female patient taking Copegus (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , 67 years of age, Patient experienced the following unwanted or unexpected effects: pulmonary haemorrhage. During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ).

6083525-5 | Skull Malformation
on Feb 07, 2009 Male patient from UNITED STATES , weighting 5.73 lb, was diagnosed with epilepsy (What is epilepsy?), hepatitis c (What is hepatitis c?), hypothyroidism and was treated with Copegus (View Usage). Patient had the following side effects: skull malformation. Copegus dosage: . During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), VIRAFERONPEG (Form Injectable Solution) (View Viraferonpeg Review and Viraferonpeg Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), DEROXAT (View Deroxat Review and Deroxat Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), CYSTINE B6 (View Cystine-b6 Review and Cystine-b6 Label ).

6082319-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Bilirubin Increased, Fatigue, Haematocrit Decreased, Haemoglobin Decreased, Neutrophil Count Decreased, No Therapeutic Response
on Jan 03, 2008 Male patient from UNITED STATES , 47 years of age, weighting 246.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood bilirubin increased, fatigue, haematocrit decreased, haemoglobin decreased, neutrophil count decreased, no therapeutic response. Copegus dosage: 1400 Mg Daily Oral. During the same period patient was treated with INFERGEN (15 Mcg Daily Subcutaenous) (View Infergen Review and Infergen Label ), NADOLOL (View Nadolol Review and Nadolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6082258-9 | Blood Bilirubin Increased
Patient was taking Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased on Feb 01, 2008 from UNITED STATES Additional patient health information: Female patient , 45 years of age, weighting 179.9 lb, was diagnosed with hepatitis c (What is hepatitis c?), hiv infection (What is hiv infection?) and. Copegus dosage: 2 Per Day Oral. During the same period patient was treated with REYATAZ (1 Per Day Oral) (View Reyataz Review and Reyataz Label ), PEGASYS (View Pegasys Review and Pegasys Label ), COMBIVIR (View Combivir Review and Combivir Label ).

6051855-9 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
Adverse event was reported on Jan 12, 2009 by a Male patient taking Copegus (View Usage) (Dosage: Route Reported As Ingestion, Overdose) . Location: UNITED STATES , 48 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest. During the same period patient was treated with HYDROCODONE BITARTRATE (Route Reported As Ingestion, Overdose) (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), ALPRAZOLAM (Route Reported As Ingestion, Overdose) (View Alprazolam Review and Alprazolam Label ), PROMETHAZINE (Route Reported As Ingestion, Overdose) (View Promethazine Review and Promethazine Label ), TADALAFIL (Route Reported As Ingestion, Overdose) (View Tadalafil Review and Tadalafil Label ). Patient was hospitalized.

6017826-3 | Thrombosis
on Dec 12, 2008 Female patient from SWITZERLAND , 59 years of age, was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: thrombosis. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

5948906-6 | Thrombotic Microangiopathy
on Oct 30, 2008 Female patient from JAPAN , 43 years of age, was diagnosed with hepatitis c (What is hepatitis c?), liver transplant rejection and was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: thrombotic microangiopathy. Copegus dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), TACROLIMUS (Form: Intravenous (not Otherwise Specified)) (View Tacrolimus Review and Tacrolimus Label ), ALPROSTADIL ALFADEX (Route: Injectable (not Otherwise Specified)) (View Alprostadil Alfadex Review and Alprostadil Alfadex Label ), EDARAVONE (Route: Injectable (not Otherwise Specified)) (View Edaravone Review and Edaravone Label ).

5923867-4 | Abortion Induced, No Adverse Event
Patient was taking Copegus (View Usage). Patient had the following side effects: abortion induced, no adverse event on Oct 13, 2008 from SPAIN Additional patient health information: Female patient , 34 years of age, weighting 132.3 lb, . Copegus dosage: Dosage Regimen Reported As 800 Mg/day.

5901156-1 | Agitation, Hyperthyroidism, Influenza, Mass, Withdrawal Syndrome
Adverse event was reported on Sep 17, 2008 by a Female patient taking Copegus (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 47 years of age, After Copegus was administered, patient had the following side effects: agitation, hyperthyroidism, influenza, mass, withdrawal syndrome. During the same period patient was treated with PEG INTERFERON ALFA 2B (View Peg-interferon Alfa 2b Review and Peg-interferon Alfa 2b Label ), CARBIMAZOLE (View Carbimazole Review and Carbimazole Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

5875473-8 | Agitation, Hyperthyroidism, Influenza, Mass
on Aug 27, 2008 Female patient from UNITED KINGDOM , 47 years of age, was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, hyperthyroidism, influenza, mass. Copegus dosage: . During the same period patient was treated with PEG INTERFERON ALFA 2B (View Peg-interferon Alfa 2b Review and Peg-interferon Alfa 2b Label ), CARBIMAZOLE (View Carbimazole Review and Carbimazole Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ).

5851551-4 | Agitation, Hyperthyroidism, Influenza, Mass, Withdrawal Syndrome
on Aug 08, 2008 Female patient from UNITED KINGDOM , 47 years of age, was treated with Copegus (View Usage). Patient had the following side effects: agitation, hyperthyroidism, influenza, mass, withdrawal syndrome. Copegus dosage: . During the same period patient was treated with PEG INTERFERON ALFA 2B (View Peg-interferon Alfa 2b Review and Peg-interferon Alfa 2b Label ), CARBIMAZOLE (View Carbimazole Review and Carbimazole Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ).

5832562-1 | Evans Syndrome
Patient was taking Copegus (View Usage). After Copegus was administered, patient had the following side effects: evans syndrome on Jul 23, 2008 from JAPAN Additional patient health information: Female patient , 48 years of age, . Copegus dosage: Reported As 'tapered And Discontinued'. During the same period patient was treated with PEGASYS (Dose Reduced) (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

5832066-6 | Stridor
Adverse event was reported on Jul 25, 2008 by a Female patient taking Copegus (View Usage) (Dosage: ) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , weighting 20.50 lb, Patient experienced the following unwanted or unexpected effects: stridor. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), DEPAKOTE (View Depakote Review and Depakote Label ), VITAMIN TAB (Total Dose Repoted As '1 Tablet') (View Vitamin Tab Review and Vitamin Tab Label ).

5802143-4 | Skull Malformation
on Jun 23, 2008 Male patient from FRANCE , weighting 5.73 lb, was diagnosed with hepatitis c (What is hepatitis c?), epilepsy (What is epilepsy?), hypothyroidism and was treated with Copegus (View Usage). Patient had the following side effects: skull malformation. Copegus dosage: . During the same period patient was treated with VIRAFERONPEG (Form Injectable Solution) (View Viraferonpeg Review and Viraferonpeg Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), DEROXAT (View Deroxat Review and Deroxat Label ), DEPAKENE (View Depakene Review and Depakene Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), CYSTINE B6 (View Cystine-b6 Review and Cystine-b6 Label ).

5783127-1 | Herpes Zoster
on Jun 20, 2008 Male patient from UNITED KINGDOM , weighting 180.3 lb, was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: herpes zoster. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

5772331-4 | Oligohydramnios, Pregnancy, Skull Malformation
Patient was taking Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: oligohydramnios, pregnancy (What is pregnancy?), skull malformation on Jun 03, 2008 from FRANCE Additional patient health information: Male patient , weighting 5.73 lb, was diagnosed with hepatitis c (What is hepatitis c?), epilepsy (What is epilepsy?), hypothyroidism and. Copegus dosage: . During the same period patient was treated with VIRAFERONPEG (Form Injectable Solution) (View Viraferonpeg Review and Viraferonpeg Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), DEPAKENE (View Depakene Review and Depakene Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), CYSTINE B6 (View Cystine-b6 Review and Cystine-b6 Label ), CYSTINE B6 (View Cystine-b6 Review and Cystine-b6 Label ).

5771765-1 | Asthenia, Leukopenia, Lymphoma, Neutropenia
Adverse event was reported on Jun 02, 2008 by a Male patient taking Copegus (View Usage) (Dosage: Other Indication: Lymphoma) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 169.1 lb, Patient had the following side effects: asthenia, leukopenia, lymphoma (What is lymphoma?), neutropenia. During the same period patient was treated with PEG INTRON (Other Indication: Lymphoma) (View Peg-intron Review and Peg-intron Label ).

5709767-3 | Disseminated Intravascular Coagulation, Multi-organ Failure, Psoas Abscess
on Apr 09, 2008 Female patient from JAPAN , 56 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: disseminated intravascular coagulation, multi-organ failure, psoas abscess. Copegus dosage: . During the same period patient was treated with PEG INTERFERON ALFA 2B (View Peg-interferon Alfa 2b Review and Peg-interferon Alfa 2b Label ). Patient was hospitalized.

5700059-5 | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Pulmonary Hypertension, Right Ventricular Failure
on Apr 01, 2008 Female patient from JAPAN , weighting 83.78 lb, was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, pulmonary hypertension (What is pulmonary hypertension?), right ventricular failure. Copegus dosage: Divided Into 2 Doses.. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ), SOLON (View Solon Review and Solon Label ), TAKEPRON (View Takepron Review and Takepron Label ), CETAPRIL (View Cetapril Review and Cetapril Label ), ZYLORIC (View Zyloric Review and Zyloric Label ).

5664822-1 | Lymphadenopathy
Patient was taking Copegus (View Usage). Patient had the following side effects: lymphadenopathy on Feb 15, 2008 from JAPAN Additional patient health information: Male patient , 70 years of age, weighting 116.8 lb, . Copegus dosage: Divided Into Two Doses.. During the same period patient was treated with PEGASYS (Dose Decreased.) (View Pegasys Review and Pegasys Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), GLYCYRON (View Glycyron Review and Glycyron Label ).

5662004-0 | Blood Bilirubin Increased
Adverse event was reported on Oct 10, 2007 by a Female patient taking Copegus (View Usage) (Dosage: 2 Per Day Oral) was diagnosed with hepatitis c (What is hepatitis c?), hiv infection (What is hiv infection?) and. Location: UNITED STATES , 45 years of age, weighting 179.9 lb, After Copegus was administered, patient had the following side effects: blood bilirubin increased. During the same period patient was treated with REYATAZ (1 Per Day Oral) (View Reyataz Review and Reyataz Label ), PEGASYS (View Pegasys Review and Pegasys Label ), COMBIVIR (View Combivir Review and Combivir Label ).

5662001-5 | Anaemia, Blood Bilirubin Increased, Jaundice
on Oct 10, 2007 Male patient from UNITED STATES , 52 years of age, weighting 167.1 lb, was diagnosed with hepatitis c (What is hepatitis c?), hiv infection (What is hiv infection?) and was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood bilirubin increased, jaundice (What is jaundice?). Copegus dosage: 400 Mg 2 Per Day. During the same period patient was treated with REYATAZ (400 Mg Daily) (View Reyataz Review and Reyataz Label ), PEGASYS (View Pegasys Review and Pegasys Label ), TRIZIVIR (View Trizivir Review and Trizivir Label ). Patient was hospitalized.

5662000-3 | Anaemia
on Oct 13, 2005 Female patient from UNITED STATES , 42 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient had the following side effects: anaemia. Copegus dosage: Oral. During the same period patient was treated with PEG INTRON (Subcutaneous) (View Peg-intron Review and Peg-intron Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), PERCOCET (OXYCODONE/PARACETAMOL) (View Percocet (oxycodone/paracetamol) Review and Percocet (oxycodone/paracetamol) Label ), PROZAC (View Prozac Review and Prozac Label ), XANAX (View Xanax Review and Xanax Label ).

5661998-7 | Anaemia
Patient was taking Copegus (View Usage). After Copegus was administered, patient had the following side effects: anaemia on Oct 03, 2005 from UNITED STATES Additional patient health information: Female patient , 62 years of age, weighting 134.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Copegus dosage: Oral. During the same period patient was treated with PEG INTRON (Subcutaneous) (View Peg-intron Review and Peg-intron Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), AMBIEN (View Ambien Review and Ambien Label ), CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ), CHONDROITIN/GLUCOSAMINE (View Chondroitin/glucosamine Review and Chondroitin/glucosamine Label ), NEXIUM (View Nexium Review and Nexium Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), VALIUM (View Valium Review and Valium Label ).

5661997-5 | Suicidal Ideation
Adverse event was reported on Sep 30, 2005 by a Female patient taking Copegus (View Usage) (Dosage: Oral) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 52 years of age, Patient experienced the following unwanted or unexpected effects: suicidal ideation. During the same period patient was treated with PEG INTRON (Subcutaneous) (View Peg-intron Review and Peg-intron Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), DIOVAN (View Diovan Review and Diovan Label ), LASIX (View Lasix Review and Lasix Label ), NORVASC (View Norvasc Review and Norvasc Label ), RESTORIL (View Restoril Review and Restoril Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

5661996-3 | Aggression, Hallucination, Auditory, Paranoia
on Sep 21, 2005 Male patient from UNITED STATES , 53 years of age, weighting 242.9 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient had the following side effects: aggression, hallucination, auditory, paranoia. Copegus dosage: Oral. During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), ALCOHOL (ALCOHOL) (View Alcohol (alcohol) Review and Alcohol (alcohol) Label ), MARIJUANA (CANNABIS) (View Marijuana (cannabis) Review and Marijuana (cannabis) Label ), COCAINE (COCAINE) (View Cocaine (cocaine) Review and Cocaine (cocaine) Label ), ELAVIL (View Elavil Review and Elavil Label ), ACETAMINOPHEN/HYDROCODONE BITARTRATE (HYDROCODONE BITARTRATE/PARACETAM (View Acetaminophen/hydrocodone Bitartrate (hydrocodone Bitartrate/paracetam Review and Acetaminophen/hydrocodone Bitartrate (hydrocodone Bitartrate/paracetam Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), POTASSIUM SUPPLEMENT (POTASSIUM NOS) (View Potassium Supplement (potassium Nos) Review and Potassium Supplement (potassium Nos) Label ). Patient was hospitalized.

5661994-X | Weight Decreased
on May 23, 2005 Male patient from UNITED STATES , 57 years of age, weighting 149.9 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: weight decreased. Copegus dosage: Oral.

5661992-6 | Anorexia, Anxiety, Asthma, Blood Glucose Increased, Constipation, Cough, Depression, Dyspnoea, Dyspnoea At Rest
Patient was taking Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, anxiety (What is anxiety?), asthma (What is asthma?), blood glucose increased, constipation (What is constipation?), cough, depression (What is depression?), dyspnoea, dyspnoea at rest on Oct 04, 2007 from UNITED STATES Additional patient health information: Male patient , 50 years of age, weighting 194.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Copegus dosage: 600 Mg 2 Per Day. During the same period patient was treated with INFERGEN (15 Mcg 1 Per Day Subcutaneous) (View Infergen Review and Infergen Label ), ZYRTEC D 12 HOUR (View Zyrtec-d 12 Hour Review and Zyrtec-d 12 Hour Label ), ASMANEX TWISTHALER (View Asmanex Twisthaler Review and Asmanex Twisthaler Label ), AFRIN (*OXYMETAZOLINE HYDROCHLORIDE/*PSEUDOPHEDRINE HYDROCHLORIDE) (View Afrin (*oxymetazoline Hydrochloride/*pseudophedrine Hydrochloride) Review and Afrin (*oxymetazoline Hydrochloride/*pseudophedrine Hydrochloride) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), CENTRUM (MINERALS NOS/MULTIVITAMIN NOS) (View Centrum (minerals Nos/multivitamin Nos) Review and Centrum (minerals Nos/multivitamin Nos) Label ), FLEXERIL (View Flexeril Review and Flexeril Label ).

5661982-3 | Asthenia, Chills, Chromaturia, Diarrhoea, Dyspnoea, Fungal Infection, Lung Infection, Pneumonia, Productive Cough
Adverse event was reported on Dec 14, 2006 by a Male patient taking Copegus (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 53 years of age, weighting 147.0 lb, Patient had the following side effects: asthenia, chills, chromaturia, diarrhoea, dyspnoea, fungal infection (What is fungal infection?), lung infection, pneumonia (What is pneumonia?), productive cough. During the same period patient was treated with PEG INTRON (Subcutaneous) (View Peg-intron Review and Peg-intron Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ALBUTEROL/IPRATROPIUM (IPRATROPIUM BROMMIDE/SALBUTAMOL) (View Albuterol/ipratropium (ipratropium Brommide/salbutamol) Review and Albuterol/ipratropium (ipratropium Brommide/salbutamol) Label ), ASTHMANEX (MOMETASONE FUROATE) (View Asthmanex (mometasone Furoate) Review and Asthmanex (mometasone Furoate) Label ), DOCUSATE (DOCUSATE SODIUM) (View Docusate (docusate Sodium) Review and Docusate (docusate Sodium) Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), ELAVIL (View Elavil Review and Elavil Label ), FORMOTEROL FUMARATE (FORMOTEROL) (View Formoterol Fumarate (formoterol) Review and Formoterol Fumarate (formoterol) Label ).

5657442-6 | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Pulmonary Hypertension, Right Ventricular Failure
on Feb 27, 2008 Female patient from JAPAN , 59 years of age, weighting 83.78 lb, was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, pulmonary hypertension (What is pulmonary hypertension?), right ventricular failure. Copegus dosage: Divided Into 2 Doses.. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ), SOLON (View Solon Review and Solon Label ), TAKEPRON (View Takepron Review and Takepron Label ), CETAPRIL (View Cetapril Review and Cetapril Label ), ZYLORIC (View Zyloric Review and Zyloric Label ).

5645104-0 | Aphasia
on Feb 18, 2008 Female patient from JAPAN , 76 years of age, was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?). Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), URSO 250 (Form: Oral Formulation.) (View Urso 250 Review and Urso 250 Label ), BLOPRESS (View Blopress Review and Blopress Label ). Patient was hospitalized.

5643275-3 | Abortion Spontaneous
Patient was taking Copegus (View Usage). Patient had the following side effects: abortion spontaneous on Feb 18, 2008 from NEW ZEALAND Additional patient health information: Male patient , 41 years of age, . Copegus dosage: . During the same period patient was treated with NUROFEN (View Nurofen Review and Nurofen Label ).

5633492-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Pulmonary Hypertension, Right Ventricular Failure
Adverse event was reported on Feb 13, 2008 by a Female patient taking Copegus (View Usage) (Dosage: Divided Into 2 Doses.) . Location: JAPAN , 59 years of age, weighting 83.78 lb, After Copegus was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, pulmonary hypertension (What is pulmonary hypertension?), right ventricular failure. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ), SOLON (View Solon Review and Solon Label ).

5629967-0 | Abortion Spontaneous
on Feb 05, 2008 Male patient from NEW ZEALAND , 41 years of age, was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Copegus dosage: . During the same period patient was treated with NUROFEN (View Nurofen Review and Nurofen Label ).

5629957-8 | Dyspnoea Exertional, Pulmonary Interstitial Emphysema Syndrome
on Feb 07, 2008 Male patient from FRANCE , 48 years of age, was treated with Copegus (View Usage). Patient had the following side effects: dyspnoea exertional, pulmonary interstitial emphysema syndrome. Copegus dosage: . During the same period patient was treated with VIRAFERON (View Viraferon Review and Viraferon Label ), NOCTAMIDE (Three Doses Daily.) (View Noctamide Review and Noctamide Label ), IMOVANE (Three Doses Daily.) (View Imovane Review and Imovane Label ), LIPANTHYL (One Dose Daily.) (View Lipanthyl Review and Lipanthyl Label ), ATARAX (One Dose Daily.) (View Atarax Review and Atarax Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LASILIX (Taken Every Morning) (View Lasilix Review and Lasilix Label ). Patient was hospitalized.

5624807-8 | Delirium
Patient was taking Copegus (View Usage). After Copegus was administered, patient had the following side effects: delirium on Feb 01, 2008 from JAPAN Additional patient health information: Female patient , 48 years of age, . Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

5622147-4 | Dyspnoea Exertional, Pulmonary Interstitial Emphysema Syndrome
Adverse event was reported on Jan 28, 2008 by a Male patient taking Copegus (View Usage) (Dosage: ) . Location: FRANCE , 48 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea exertional, pulmonary interstitial emphysema syndrome. During the same period patient was treated with VIRAFERON (View Viraferon Review and Viraferon Label ), NOCTAMIDE (View Noctamide Review and Noctamide Label ), IMOVANE (View Imovane Review and Imovane Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), ATARAX (View Atarax Review and Atarax Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LASILIX (Taken Every Morning) (View Lasilix Review and Lasilix Label ). Patient was hospitalized.

5620196-3 | Dizziness, Hypotension, Loss Of Consciousness
on Jan 25, 2008 Male patient from JAPAN , 49 years of age, was treated with Copegus (View Usage). Patient had the following side effects: dizziness (What is dizziness?), hypotension, loss of consciousness. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

5602572-8 | Retinal Detachment
on Jan 15, 2008 Female patient from JAPAN , 69 years of age, weighting 105.8 lb, was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: retinal detachment. Copegus dosage: Divided Into Two Doses. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

5563338-0 | Infant, Phenylalanine Screen Positive, Plagiocephaly, Torticollis
Patient was taking Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: infant (What is infant?), phenylalanine screen positive, plagiocephaly, torticollis on Dec 06, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 5.29 lb, . Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

5541916-2 | Retinal Detachment
Adverse event was reported on Nov 29, 2007 by a Female patient taking Copegus (View Usage) (Dosage: Divided Into Two Doses) . Location: JAPAN , 69 years of age, Patient had the following side effects: retinal detachment. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

5527949-0 | Memory Impairment
on Nov 16, 2007 Male patient from JAPAN , 58 years of age, weighting 123.5 lb, was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: memory impairment. Copegus dosage: 1200 Mg Divided Into 2 Doses. Dose Decreased. During the same period patient was treated with PEGASYS (Dose Decreased) (View Pegasys Review and Pegasys Label ), EURODIN (View Eurodin Review and Eurodin Label ), HALCION (View Halcion Review and Halcion Label ), DEPAS (View Depas Review and Depas Label ), BLOPRESS (View Blopress Review and Blopress Label ), LOXONIN (View Loxonin Review and Loxonin Label ).

5525290-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Infectious Mononucleosis
on Nov 12, 2007 Male patient from GERMANY , 30 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, infectious mononucleosis (What is infectious mononucleosis?). Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

5519321-4 | Transaminases Increased
Patient was taking Copegus (View Usage). Patient had the following side effects: transaminases increased on Nov 07, 2007 from FRANCE Additional patient health information: Female patient , 63 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).